Aliases:This biomarker is also known as:
- endoplasmic reticulum-associated amyloid beta-peptide-binding protein,
- Mitochondrial ribonuclease P protein 2,
- Short-chain type dehydrogenase/reductase XH98G2,
- short chain type dehydrogenase/reductase XH98G2,
- hydroxyacyl-Coenzyme A dehydrogenase, type II, hydroxyacyl-Coenzyme A dehydrogenase, type II,
- 17-beta-hydroxysteroid dehydrogenase 10,
- EC 184.108.40.206,EC 220.127.116.11,
- hydroxysteroid (17-beta) dehydrogenase 10,
- amyloid-beta peptide binding alcohol dehydrogenase,
- mitochondrial ribonuclease P protein 2,
- Type II HADH,
- short chain L-3-hydroxyacyl-CoA dehydrogenase type 2,
- short chain dehydrogenase/reductase family 5C, member 1,
- 3-hydroxyacyl-CoA dehydrogenase type II,
- 3-hydroxyacyl-CoA dehydrogenase type-2,
- AB-binding alcohol dehydrogenase,
- 3-hydroxy-2-methylbutyryl-CoA dehydrogenase,
- mental retardation, X-linked, syndromic 10,
- Mitochondrial RNase P protein 2,
- Endoplasmic reticulum-associated amyloid beta-peptide-binding protein,
- 17-beta-HSD 10,
- mitochondrial RNase P subunit 2,
HSD17B10, hydroxysteroid (17-beta) dehydrogenase 10, is a member of the short-chain dehydrogenase/reductase superfamily. HSD17B10 functions in mitochondrial tRNA maturation and catalyzes the oxidation of a wide variety of fatty acids, alcohols, and steroids. The protein is thought to play a role in the development of Alzheimer's disease. There are several alternatively spliced transcript variants, of which only two have been fully sequenced.
There are no datasets associated with this biomarker.
The following organs have data associated with this biomarker…
|QA State:||Under Review|
No additional breast data is available.
HSD17B10 was one of numerous potential early detection biomarkers specific to triple-negative breast cancer in multiple pathways identified.